Substituted quinazolines as receptor-type kinase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9796704
SERIAL NO

14845763

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides compounds of structural formula I,

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SYMPHONY EVOLUTION INC7361 CALHOUN PLACE SUITE 325 ROCKVILLE MD 20850

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Anand, Neel K Burlingame, US 25 68
Blazey, Charles M San Francisco, US 21 293
Bussenius, Joerg Foster City, US 23 354
Costanzo, Simona Los Altos, US 20 189
Kennedy, Abigail R San Leandro, US 19 330
Peto, Csaba J Alameda, US 28 366
Rice, Kenneth D Mill Valley, US 33 558
Tsang, Tsze H El Cerrito, US 31 483

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 24, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 24, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00